中国实验诊断学
中國實驗診斷學
중국실험진단학
CHINESE JOURNAL OF LABORATORY DIAGNOSIS
2014年
10期
1626-1628
,共3页
刘玲%殷屹岗%阮中宝%陈各才%朱莉
劉玲%慇屹崗%阮中寶%陳各纔%硃莉
류령%은흘강%원중보%진각재%주리
瑞舒伐他汀%冠状动脉造影%冠心病%ELISA%Cys-c%Hcy
瑞舒伐他汀%冠狀動脈造影%冠心病%ELISA%Cys-c%Hcy
서서벌타정%관상동맥조영%관심병%ELISA%Cys-c%Hcy
Rosuvastatin%Coronary angiography%Coronary artery disease%ELISA%Cys-c%Hcy
目的:观察瑞舒伐他汀干预后不同严重程度的冠心病患者血清 Cys-c和 Hcy水平的变化。方法选择来我院就诊经冠状动脉造影确诊为冠心病患者40例(冠脉单支病变11例、冠脉双支病变16例和冠脉多支病变13例),分为两组(n=40):瑞舒伐他汀治疗前组和瑞舒伐他汀治疗后组(瑞舒伐他汀10 mg/d),同期体检健康人20例作为正常对照组;初次检查、治疗6个月后均空腹采血及冠状动脉造影。采用 ELISA法检测血清中Cys-c和 Hcy的水平;采用冠状动脉造影测定斑块的个数、厚度、性质。结果(1)治疗前与正常对照组相比较,患者血清Cys-c和 Hcy水平均显著升高有统计学意义(P<0.01);均为冠脉多支病变高于冠脉双支病变及冠脉单支病变,组间比较有统计学意义(P<0.01)。(2)治疗后与正常对照组相比较,瑞舒伐他汀干预组患者血清Cys-c和 Hcy水平略升高且冠脉多支病变、冠脉双支病变、冠脉单支病变组均明显低于治疗前(P<0.01),但三组间无统计学意义(P>0.05)。(3)瑞舒伐他汀干预组治疗后患者血清Cys-c和 Hcy水平明显低于治疗前有统计学意义(P<0.01),斑块个数无差异(P>0.05),斑块厚度变薄、斑块由软斑块变为硬斑块的百分率大(P<0.01)。结论血清Cys-c和 Hcy水平随病变严重程度而升高,瑞舒伐他汀能通过降低血清Cys-c和 Hcy水平,使得斑块变薄,并能促进斑块硬化,从而改善冠心病患者冠状动脉病变的程度。
目的:觀察瑞舒伐他汀榦預後不同嚴重程度的冠心病患者血清 Cys-c和 Hcy水平的變化。方法選擇來我院就診經冠狀動脈造影確診為冠心病患者40例(冠脈單支病變11例、冠脈雙支病變16例和冠脈多支病變13例),分為兩組(n=40):瑞舒伐他汀治療前組和瑞舒伐他汀治療後組(瑞舒伐他汀10 mg/d),同期體檢健康人20例作為正常對照組;初次檢查、治療6箇月後均空腹採血及冠狀動脈造影。採用 ELISA法檢測血清中Cys-c和 Hcy的水平;採用冠狀動脈造影測定斑塊的箇數、厚度、性質。結果(1)治療前與正常對照組相比較,患者血清Cys-c和 Hcy水平均顯著升高有統計學意義(P<0.01);均為冠脈多支病變高于冠脈雙支病變及冠脈單支病變,組間比較有統計學意義(P<0.01)。(2)治療後與正常對照組相比較,瑞舒伐他汀榦預組患者血清Cys-c和 Hcy水平略升高且冠脈多支病變、冠脈雙支病變、冠脈單支病變組均明顯低于治療前(P<0.01),但三組間無統計學意義(P>0.05)。(3)瑞舒伐他汀榦預組治療後患者血清Cys-c和 Hcy水平明顯低于治療前有統計學意義(P<0.01),斑塊箇數無差異(P>0.05),斑塊厚度變薄、斑塊由軟斑塊變為硬斑塊的百分率大(P<0.01)。結論血清Cys-c和 Hcy水平隨病變嚴重程度而升高,瑞舒伐他汀能通過降低血清Cys-c和 Hcy水平,使得斑塊變薄,併能促進斑塊硬化,從而改善冠心病患者冠狀動脈病變的程度。
목적:관찰서서벌타정간예후불동엄중정도적관심병환자혈청 Cys-c화 Hcy수평적변화。방법선택래아원취진경관상동맥조영학진위관심병환자40례(관맥단지병변11례、관맥쌍지병변16례화관맥다지병변13례),분위량조(n=40):서서벌타정치료전조화서서벌타정치료후조(서서벌타정10 mg/d),동기체검건강인20례작위정상대조조;초차검사、치료6개월후균공복채혈급관상동맥조영。채용 ELISA법검측혈청중Cys-c화 Hcy적수평;채용관상동맥조영측정반괴적개수、후도、성질。결과(1)치료전여정상대조조상비교,환자혈청Cys-c화 Hcy수평균현저승고유통계학의의(P<0.01);균위관맥다지병변고우관맥쌍지병변급관맥단지병변,조간비교유통계학의의(P<0.01)。(2)치료후여정상대조조상비교,서서벌타정간예조환자혈청Cys-c화 Hcy수평략승고차관맥다지병변、관맥쌍지병변、관맥단지병변조균명현저우치료전(P<0.01),단삼조간무통계학의의(P>0.05)。(3)서서벌타정간예조치료후환자혈청Cys-c화 Hcy수평명현저우치료전유통계학의의(P<0.01),반괴개수무차이(P>0.05),반괴후도변박、반괴유연반괴변위경반괴적백분솔대(P<0.01)。결론혈청Cys-c화 Hcy수평수병변엄중정도이승고,서서벌타정능통과강저혈청Cys-c화 Hcy수평,사득반괴변박,병능촉진반괴경화,종이개선관심병환자관상동맥병변적정도。
Objective To observe the change of Cys-c and Hcy level in the serum of the coronary heart disease pa-tients with different severity after the intervention of rosuvastatin.Methods Options to our hospital diagnosed by coro-nary angiography 40 patients with coronary heart disease (single vessel coronary artery disease 1 1 cases,dual vessel cor-onary artery disease 16 cases,multi-vessel coronary artery disease 13 cases),divided into two groups(n=40):Before treatment with rosuvastatin group and rosuvastatin treatment group(rosuvastatin 10 mg/d),physical health of people 20 cases over the same period as the normal control group;Initial inspection,after 6 months of treatment both fasting blood and coronary angiography.Detected by ELISA in serum Cys-c and Hcy level;Measured by coronary angiography plaque number,thickness,nature.Results (1)Before treatment compared with the control group,Cys-c and Hcy level in the serum of the patients were significantly higher statistically significant(P<0.01);Coronary multi-vessel disease are higher than double coronary artery disease and higher than single vessel disease and have statistically significant(P<0.01);(2)After treatment compared with the control group,Cys-c and Hcy level in the serum of rosuvastatin inter-vention groups were slightly elevated and among multi-vessel disease,double coronary artery disease and single vessel coronary artery disease was not statistically significant(P>0.05).(3)Rosuvastatin intervention groups the levels of Cys-c and Hcy in the serum were significantly lower than before treatment was statistically significant(P<0.01),no difference in the number of plaques(P>0.05),plaque thickness thining spots large blocks into soft plaque and hard plaque percentage(P<0.01).Conclusion Serum Cys-c and Hcy levels increased with disease severity,rosuvastatin by reducing serum Cys-c and Hcy levels,making the plaque thining and promote plaque sclerosis,thereby improving coro-nary heart disease severity of coronary artery disease.